BamSEC and AlphaSense Join Forces
Learn More

Zivo Bioscience Inc. – Material Contracts

OTC: ZIVO    
Share price (7/1/26): $4.20    
Market cap (7/1/26): $16.3 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 8 pages Independent Contractor Services Agreement
12/34/56
EX-10.1
from 8-K 6 pages Separation Agreement This Agreement Dated as of December 19, 2025 (“Agreement”) Is Made by and Between Zivo Bioscience, Inc. (The “Company”) and Keith R. Marchiando (“Executive”). Whereas, Executive Is Employed as the Chief Financial Officer of the Company, Whereas, the Parties Wish to Enter Into This Agreement Regarding Their Separation. Accordingly, in Consideration of the Execution and Delivery of This Agreement and the Compliance With the Promises Made Herein, the Parties Agree That the Precatory Clauses Above Are Incorporated Herein and Further Agree as Follows
12/34/56
EX-10.1
from 8-K 9 pages Bridge Promissory Note
12/34/56
EX-10.1
from 8-K 6 pages Exchange Agreement
12/34/56
EX-10.1
from 8-K 25 pages Debt Settlement Agreement
12/34/56
EX-10.3
from 8-K 1 page First Amendment to Zivo Bioscience, Inc, 2021 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 2 pages Compensation Policy
12/34/56
EX-10.1
from 8-K 38 pages Form Grant Agreements
12/34/56
EX-10.1
from 8-K 9 pages Subscription Agreement
12/34/56
EX-10.13
from S-1/A 9 pages [*], 2023 Zivo Bioscience, Inc. 21 E. Long Lake Road, Suite 100 Bloomfield Hills, MI 48304 Attention: John B. Payne Re: Placement Agency Agreement Dear Mr. Payne
12/34/56
EX-10.12
from S-1/A 5 pages Lock-Up Agreement
12/34/56
EX-10.11
from S-1/A 41 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 36 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 10 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both Not Material and Is of the Type That the Company Treats as Private or Confidential. Double Asterisks Denote Omissions. Subscription Agreement
12/34/56
EX-10.11
from S-1 16 pages Placement Agency Agreement
12/34/56
EX-10.10
from S-1 30 pages Securities Purchase Agreement
12/34/56
EX-10.4
from S-1 2 pages First Amendment to Employment Agreement
12/34/56
EX-10.8
from 10-K 2 pages Zivo Bioscience, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 8-K 44 pages Zivo Bioscience, Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: September 4, 2021 Approved by the Stockholders: October 12, 2021
12/34/56
EX-10.1
from 8-K 7 pages Employment Agreement
12/34/56